National Cancer Institute "Cancer Moonshot Biobank"
Recruiting
1,600 enrolled
Evaluation for NCI Surgery Branch Clinical Research Protocols
Recruiting
7,000 enrolled
PD-L1 Targeting Peptide Probe for PET Imaging of Solid Tumor
Not yet recruiting
40 enrolled
Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting
Withdrawn
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Recruiting
100 enrolled
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Recruiting
2,000 enrolled
iCaRe2
Recruiting
999,999 enrolled
ELEPHAS-02
Recruiting
416 enrolled
Evaluation of Anti-PD-1 Therapy by Monitoring T Cell Responses in Melanoma, Lung and Other Cancer Types
Recruiting
500 enrolled
TraveraRTGx
Recruiting
200 enrolled
Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment
Enrolling by invitation
1,200 enrolled
SBRT
Completed
98 enrolled
A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
Recruiting
350 enrolled
Tempus Priority Study: A Pan-tumor Observational Study
Active not recruiting
1,000 enrolled
SURVIMON
Active not recruiting
100,000 enrolled
Eligibility Screening for the NIH Intramural Research Program Clinical Protocols
Completed
19,522 enrolled
Genomic Testing and Resulting Medical Decisions
Completed
1,500 enrolled
PREFER
Completed
1,429 enrolled
MOHCCN-O
Recruiting
500 enrolled
OCTANE
Recruiting
10,000 enrolled
QUANTUM
Enrolling by invitation
3,000 enrolled
SkinHealth
Recruiting
420 enrolled
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
Completed
484 enrolled
Pattern of Use and Safety/Effectiveness of Nivolumab in Routine Oncology Practice
Completed
1,189 enrolled
CER
Recruiting
15,000 enrolled
POSITive
Recruiting
265 enrolled
PatientSpot Formerly Known as ArthritisPower
Unknown
40,000 enrolled
CANINE
Unknown
500 enrolled
G-DEFINER
Completed
247 enrolled
Microbiome Immunotherapy Toxicity and Response Evaluation
Unknown
1,800 enrolled
A Tissue Collection Study in Patients Who Respond to Immune Checkpoint Inhibitors to Identify Targets of Tumor-Reactive T Cells.
Unknown
200 enrolled
Generation of Cancer Antigen-Specific T-cells From Human Induced Pluripotent Stem Cells (iPSC) for Research and Potential FutureTherapy
Terminated
98 enrolled
Open-label, Uncontrolled, Non-Interventional, Retrospective Study to Evaluate Molecular Determinants of Outcome to the Immune Checkpoint Inhibitors (Anti-PD-1/Anti-PD-L1 Monoclonal Antibodies) Treatment for Solid Tumors
Unknown
400 enrolled
PIONEER
Unknown
1,000 enrolled
Health Communication in Families
Completed
42 enrolled
ICI-DISCOVER
Unknown
200 enrolled
N1
Terminated
23 enrolled
18F-fluorodeoxyglucose (18F-FDG) Positron Emission Tomography in Oncology
Completed
39,242 enrolled
PAMCap
Completed
32 enrolled
Anonymous Testing of Pathology Specimens for BRCA Mutations in Ashkenazi Jewish Individuals Who Have Cancer
Withdrawn
Study of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer.
Completed
803 enrolled
Outpatient Chest Tube Management Following Thoracic Resection Improves Patient Length of Stay and Satisfaction Without Compromising Outcomes
Terminated
12 enrolled 3 charts
B-Receptor Signaling in Cardiomyopathy
Completed
99 enrolled
Characterization of Brain Metastases
Completed
26 enrolled
Proton MR Spectroscopy of Brain Metastases in Evaluation of Treatment Response.
Withdrawn